| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 135.595.117 $ | -12.952.392 $ | +41,8 % | 3 | 148.547.509 $ | +38.909.366 $ | +18,6 % | 3 | 109.638.143 $ | +53.106.727 $ | +101,1 % | 3 | ||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 101.206.166 $ | -16.214.887 $ | -13,8 % | 1 | 117.421.053 $ | +38.199.747 $ | +48,2 % | 1 | 79.221.306 $ | +34.704.070 $ | +78,0 % | 1 |
| Rapport Therapeutics, Inc. | RAPP | → 0 | Neutral | 30.326.831 $ | +920.757 $ | +3,1 % | 1 | 29.406.074 $ | +620.299 $ | +2,2 % | 1 | 28.785.775 $ | +17.765.766 $ | +161,2 % | 1 |
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 4.062.120 $ | +2.341.738 $ | +136,1 % | 1 | 1.720.382 $ | +89.320 $ | +5,5 % | 1 | 1.631.062 $ | +636.891 $ | +64,1 % | 1 |
| 135.595.117 $ | -12.952.392 $ | +41,8 % | 3 | 148.547.509 $ | +38.909.366 $ | +18,6 % | 3 | 109.638.143 $ | +53.106.727 $ | +101,1 % | 3 | ||||